Roche Vitamins and Minerals Premix Plant, South Africa
Hoffman La Roche AG completed the construction of phase one of their new vitamins and minerals premix plant at Isando, in the Republic...
AstraZeneca Solid Forms Production Plant, Cairo, Egypt
AstraZeneca's pharmaceutical production facility in Sixth of October City (Madinat Sittah Uktubar), near Cairo, produces a broad range of the company's product portfolio...
Julphar Manufacturing Facility, Addis Ababa, Ethiopia
UAE-based pharmaceutical firm Gulf Pharmaceutical Industries (Julphar) officially opened a new pharmaceuticals manufacturing facility in February 2013. The new plant is located at Gerji...
SBL Vaccin Cholera Vaccine Production, Sweden
In the second quarter of 2003 the Swedish vaccine producer, SBL Vaccin AB, brought on-line a major extension and upgrade to the vaccine...
Polpharma Dry Forms II Production Facility, Poland
Polpharma began production at its new Dry Forms II plant (Oddzial Formy Suche II – FSII Solid Forms Branch) in Starogard Gdansk, Poland in...
GlaxoSmithKline Vaccine Manufacturing Plant, St-Amand-Les-Eaux, France
GSK Biologicals, the vaccine division of the pharmaceutical and healthcare company GlaxoSmithKline (GSK), announced its decision to build a new production facility in St-Amand-Les-Eaux,...
Cordis Corporation Manufacturing Plant, Cashel, Co Tipperary, Ireland
Cordis Corporation was established in Miami in Florida, US in 1959. The company is a subsidiary of the pharmaceutical major Johnson & Johnson, producing...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...